SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Aardvark Adventures -- Ignore unavailable to you. Want to Upgrade?


To: ~digs who wrote (639)7/26/2004 8:15:17 PM
From: ~digs  Read Replies (1) | Respond to of 7944
 
DFIB @ 2.8 +22%

stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!Ul14!Uk14]&pref=G

IRVINE, Calif., July 26 /PRNewswire-FirstCall/ -- Cardiac Science, Inc. (Nasdaq: DFIB - News), a leading manufacturer of life-saving automatic public access defibrillators (AEDs) and provider of comprehensive AED/CPR training and program management services, announced today that it continues to experience strong demand for its Powerheart® AEDs and training services from the U.S. corporate workplace segment and that marketing initiatives aimed at identifying new potential customers have led to a significant expansion of the sales pipeline that is expected to drive revenue growth over the quarters ahead.
biz.yahoo.com